Non-genomic actions of estradiol and 4-OH-tamoxifen on murine breast cancer cells | ||
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología | |
| dc.contributor.author | Raffo, Diego Alejandro | |
| dc.contributor.author | Pontiggia, Osvaldo Alejandro | |
| dc.contributor.author | Bal, Elisa Dora | |
| dc.contributor.author | Simian, Marina | |
| dc.date.issued | 2015-01 | |
| dc.description.abstract | Estrogens and tamoxifen do not only exert their effects at the genomic level, but also play a role at the cell membrane activating downstream signaling pathways. We recently characterized an estrogen receptor-positive epithelial murine breast cancer cell line, LM05-E. Utilizing this cell line and MCF-7 cells, we compared the non-genomic effects of estradiol and 4-OH-tamoxifen. We showed that, similar to estradiol, tamoxifen activated the MAPK/ERK 1/2 pathway; however, we did not find activation of PI3K/AKT by either estradiol or tamoxifen. Short-term treatments with estradiol stimulated, whereas tamoxifen inhibited cell proliferation. Using pharmacological inhibitors we showed that the effect of estradiol was mediated by the MAPK/ERK 1/2 pathway, but that inhibition of this pathway did not affect tamoxifen. Surprisingly, however, blocking of PI3K/AKT signaling interfered with the inhibitory effect of tamoxifen. Analysis of the involvement of the EGFR support previous findings that designate this receptor as a mediator of the non-genomic effects of estradiol; blocking EGFR also reverses the inhibitory effect of tamoxifen. Finally, matrix metalloproteinases (MMPs) were confirmed to be involved in the proliferative effect of estradiol. These results demonstrated the novel non-genomic effects of tamoxifen and revealed that pathways downstream of EGFR and PI3K/AKT are involved in the inhibition of cell proliferation. Caution should be exercised when analyzing strategies that aim at combining endocrine therapy with specific signaling inhibitors. | es |
| dc.description.fil | Fil: Raffo, Diego Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología ; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Pontiggia, Osvaldo Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología ; Argentina | |
| dc.description.fil | Fil: Bal, Elisa Dora. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología ; Argentina | |
| dc.description.fil | Fil: Simian, Marina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología ; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Raffo, Diego Alejandro; Pontiggia, Osvaldo Alejandro; Bal, Elisa Dora; Simian, Marina; Non-genomic actions of estradiol and 4-OH-tamoxifen on murine breast cancer cells; Spandidos Publications; Oncology Reports; 33; 1; 1-2015; 439-447 | es |
| dc.identifier.eissn | 1791-2431 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1021-335X | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/37886 | |
| dc.journal.ciudad | Atenas | es |
| dc.journal.number | 1 | es |
| dc.journal.pagination | 439-447 | es |
| dc.journal.pais | Grecia | es |
| dc.journal.title | Oncology Reports | es |
| dc.journal.volume | 33 | es |
| dc.language.iso | eng | es |
| dc.publisher | Spandidos Publications | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3892/or.2014.3558 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.spandidos-publications.com/or/33/1/439 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Breast Cancer | es |
| dc.subject | Estradiol | es |
| dc.subject | Tamoxifen | es |
| dc.subject | Non Genomic Pathways | es |
| dc.subject | Non Genomic Signaling | es |
| dc.subject.classification | Inmunología | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Non-genomic actions of estradiol and 4-OH-tamoxifen on murine breast cancer cells | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.5df31c08-a09a-4713-9f8d-c95d02b54a52_A.pdf
- Tamaño:
- 586.89 KB
- Formato:
- Adobe Portable Document Format